Prophylactic substance or composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

99/1, 167/205, 1

A61K 31/557 (2006.01) A61K 31/20 (2006.01)

Patent

CA 1225597

TITLE: "PROPHYLACTIC SUBSTANCE OR COMPOSITION" APPLICANT: JAKOBUS BOOYENS ABSTRACT The invention concerns a method of preventing the multiplication of viable cancer cells by the regular administration of a prophylactic amount of a precursor for the production, in vivo of one or more of the following eicosanoid mixtures Image and particularly GLA, AA and/or EPA, PGE1 and TXA2 are potent intracellular regulators of the biochemistry of all normal cells. TXA2 however cannot function in the absence of PGE1. Horrobin surmised that a deficiency of PGE1 and thus disabled TXA2 will cause an abnormal metabolism of the cell, of sufficient magnitude to trigger off uncontrolled division or potential cancel cells. Horrobin thus proposed that inter alia a GLA supplement should be given to cancer patients receiving conventional treatment, in order to test his hypothesis, namely, that in bypassing the metabolic block caused by an inhibited delta-6-desaturase (d-6-d) activity, it should be possible to normalise cancer cells by reverse transformation. According to the invention a prophylactic method

437205

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prophylactic substance or composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prophylactic substance or composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic substance or composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1242338

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.